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Organophosphorus (OP) pesticides are among
the most widely used pesticides in the
United States and are used in both agricultural
and residential settings. Approximately
40 OP pesticides are registered with the U.S.
Environmental Protection Agency (U.S. EPA)
for use in the United States (U.S. EPA 2003).
Examples of commonly used OP pesticides are
chlorpyrifos (Dursban), diazinon (Dianon),
azinphos methyl (Guthion), and oxydemeton-
methyl (Metasystox-R). OP pesticides are
popular because of their broad spectrum of
applications and potent toxicity to insects, their
relative inexpensive costs, and their decreased
likelihood for pest resistance (Karalliedde et al.
2001). According to U.S. EPA sales data, OP
pesticides account for about half of all insecti-
cides used in the United States. About 80 mil-
lion pounds of OP pesticides are used annually
in the United States, with 75% of their use in
agriculture (U.S. EPA 1991). Crops on
approximately 38 million acres of farmland are
treated annually with OP insecticides (U.S.
EPA 1991). A smaller percentage of the total
OP use has been in residential settings.
Whitmore et al. (2003) found that nearly half
of U.S. households with a child younger than
5 years of age had a pesticide stored within a
child’s reach. In outdoor settings in contact
with light and water, OP pesticides degrade
relatively rapidly. However, when used indoors
or as a part of structural treatments, these com-
pounds can remain stable for much longer
periods (Fenske et al. 2000) and can remain
potentially available for repeated exposure for
both adults and children.
Most OP pesticides have the same general
structure (Figure 1), a common mode of
action as an insecticide, and a common mode
of acute toxicity in humans and other animals
(Mileson et al. 1998). In vivo, these pesticides
are potent inhibitors of the enzyme acetyl
cholinesterase (AChE), which breaks down
the neurotransmitter acetylcholine. More
specifically, the hydroxyl group of a serine
residue in the active site of AChE chemically
reacts with the OP pesticide or its metaboli-
cally activated form to chemically bind the
enzyme and prevent it from performing its
natural function. In most instances, the origi-
nal enzyme may be regenerated via a simple
hydrolysis, similar to its regeneration after
breaking down acetylcholine.
Most OP pesticides are composed of a
phosphate (or phosphorothioate or phosphoro-
dithioate) moiety that, in most cases, is
O,O-dialkyl substituted, where the alkyl groups
are usually dimethyl or diethyl, and an organic
group (Figure 1). For example, diazinon is
composed of an O,O-diethyl phosphoro-
thioate to which a 2-isopropyl-4-methyl-6-
hydroxypyrimidinyl group is attached. Once
entering the body, OPs can be enzymatically
converted to their oxon form, which then
reacts with available cholinesterase. The oxon
also can be enzymatically or spontaneously
hydrolyzed to form a dialkyl phosphate (DAP)
metabolite and the organic group moiety. In the
case of diazinon, diethylphosphate (DEP) and
2-isopropyl-4-methyl-6-hydroxypyrimidine
(IMPY) may be formed. If the pesticide is not
converted to its oxon form, it can undergo
hydrolysis to its organic group metabolite and
dialkylthionate metabolites (i.e., dialkylthio-
phosphate and/or dialkyldithiophosphate).
For diazinon, these metabolites are diethyl-
thiophosphate (DETP) and IMPY. These
metabolites and/or their glucuronide or sulfate
conjugates are excreted in urine.
After the National Research Council’s
1993 report, which focused on dietary pesti-
cide exposure among infants and children, the
advantages of using OP pesticides were scruti-
nized because of the potential consequences
of childhood exposures. Consequently, the
passage of the Food Quality Protection Act
(FQPA) of 1996 required the U.S. EPA to
reassess all pesticide residue tolerances on food
and, in this reassessment, to give special con-
sideration to potential cumulative and aggre-
gate exposures to children. OP pesticides were
the ﬁrst class of pesticides for which tolerances
were reassessed because of their common mode
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We report population-based concentrations, stratified by age, sex, and racial/ethnic groups, of
dialkyl phosphate (DAP) metabolites of multiple organophosphorus pesticides. We measured
dimethylphosphate (DMP), dimethylthiophosphate (DMTP), dimethyldithiophosphate
(DMDTP), diethylphosphate (DEP), diethylthiophosphate (DETP), and diethyldithiophosphate
(DEDTP) concentrations in 1,949 urine samples collected in U.S. residents 6–59 years of age dur-
ing 1999 and 2000 as a part of the ongoing National Health and Nutrition Examination Survey
(NHANES). We detected each DAP metabolite in more than 50% of the samples, with DEP
being detected most frequently (71%) at a limit of detection of 0.2 µg/L. The geometric means for
the metabolites detected in more than 60% of the samples were 1.85 µg/L for DMTP and
1.04 µg/L for DEP. The 95th percentiles for each metabolite were DMP, 13 µg/L; DMTP,
46 µg/L; DMDTP, 19 µg/L; DEP, 13 µg/L; DETP, 2.2 µg/L; and DEDTP, 0.87 µg/L. We deter-
mined the molar sums of the dimethyl-containing and diethyl-containing metabolites; their geo-
metric mean concentrations were 49.4 and 10.5 nmol/L, respectively, and their 95th percentiles
were 583 and 108 nmol/L, respectively. These data are also presented as creatinine-adjusted con-
centrations. Multivariate analyses showed concentrations of DAPs in children 6–11 years of age
that were consistently significantly higher than in adults and often higher than in adolescents.
Although the concentrations between sexes and among racial/ethnic groups varied, no signiﬁcant
differences were observed. These data will be important in evaluating the impact of organophos-
phorus pesticide exposure in the U.S. population and the effectiveness of regulatory actions.
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long-term health effects (U.S. EPA 2003).
Because of increasing concern about the safety
of these pesticides to children, many OP pesti-
cide uses, such as residential use of chlorpyrifos
and diazinon, are being eliminated.
Because exposure to OP pesticides occurs
typically by multiple routes and the dominant
routes of exposure for individuals vary, quan-
tification of OP exposure is not a trivial
process. Therefore, in many epidemiologic
studies, markers of exposure in biologic sam-
ples have been measured to estimate the
absorbed dose (Aprea et al. 1996; Curl et al.
2002; Loewenherz et al. 1997; Lu et al. 2001;
Mills and Zahm 2001; Whyatt and Barr
2001). One of the most common ways to
assess OP pesticide dose is quantifying six com-
mon urinary DAP metabolites. These measure-
ments may provide information on class
exposure to OP pesticides or exposure to the
DAP itself that may be present in the environ-
ment as a breakdown product of OP pesticides
(environmental DAP). Although no published
studies have documented the environmental
presence or biologic absorption of environ-
mental DAPs or their contribution to urinary
DAP concentrations in humans, researchers
widely recognize their potential contributions
to urinary levels largely based on data demon-
strating similar environmental exposures,
absorption, and excretion for more selective
OP metabolites (Barr et al. 2002; Curl et al.
2003a; Krieger et al. 2003; Wilson et al. 2003).
In addition, the potential health effects result-
ing from exposure to environmental DAPs
have not been evaluated. Although the DAP
measurements provide no speciﬁc information
about the pesticide to which one was exposed
and they may potentially represent exposure to
the pesticide itself and/or its environmental
degradate, urinary DAP metabolites still pro-
vide useful information about cumulative
exposure to OP pesticides as a class because
about 75% of the U.S. EPA–registered OP
pesticides form one to three of these six DAP
metabolites. However, these concentrations are
often difficult to interpret because reference
concentrations are not available.
We report DAP metabolite concentrations
in urine samples collected in 1999 and 2000
from approximately 2,000 persons 6–59 years
of age from the U.S. general population.
Speciﬁcally, we report urinary concentrations of
dimethylphosphate (DMP), DEP, dimethyl-
thiophosphate (DMTP), DETP, dimethyl-
dithiophosphate (DMDTP), and diethyl-
dithiophosphate (DEDTP). The data we report
are representative of the civilian, noninstitu-
tionalized U.S. population and are stratiﬁed by
age, sex, and race/ethnicity.
Materials and Methods
Study design. The National Health and
Nutrition Examination Survey (NHANES),
conducted by the National Center for Health
Statistics (NCHS) of the Centers for Disease
Control and Prevention (CDC), is designed to
measure the health and nutrition status of the
civilian noninstitutionalized U.S. population
(CDC 2003a). In 1999, NHANES became a
continuous survey, ﬁelded on an ongoing basis.
Each year of data collection is based on a repre-
sentative sample covering all ages of the civilian
noninstitutionalized population. Data ﬁles are
released for public use in 2-year groupings
(cycles). National population estimates for
DAPs as well as estimates for the three largest
racial/ethnic subgroups in the U.S. population
(non-Hispanic white, non-Hispanic black, and
Mexican American) are derived from the
first 2-year cycle of the survey, NHANES
1999–2000.
The sampling scheme for NHANES is
based on a complex multistage area probability
design, which includes selection of primary
sampling units (counties), household segments
within the counties, and ﬁnally sample persons
from selected households. In 1999 and 2000,
persons 12–19 years of age and ≥ 60 years of
age, non-Hispanic blacks, and Mexican
Americans were oversampled. Low-income
white Americans were oversampled in 2000. In
addition, in 1999 and 2000, most women who
indicated that they were pregnant in the
screening interview were selected into the sam-
ple to increase the sample size for pregnant
women. Data were collected through a house-
hold interview and a standardized physical
examination, which was conducted in a mobile
examination center. Urine specimens were col-
lected from each participant ≥ 6 years of age
during one of three daily scheduled examina-
tion periods (i.e., morning, afternoon, and
early evening). Sociodemographic information
and medical histories of the survey participant
and the family were collected during the
household interview.
NHANES 1999–2000 was conducted in
26 locations throughout the United States and
included examinations of 9,282 persons. For
the DAP metabolites, measurements were
conducted on a subset of participants that
were selected based on a random one-half
sample of children 6–11 years of age in 1999
and 2000, a random one-quarter sample of
people 12–59 years of age in 1999, and a ran-
dom one-third sample of people 12–59 years
of age in 2000. Because the subset was a ran-
dom selection from the entire set, the repre-
sentativeness of the survey was maintained.
Laboratory methods. During the physical
examinations, “spot” or “grab” urine speci-
mens were collected from participants,
aliquoted, and stored cold (2–4°C) or frozen
until shipment. Urinary creatinine concentra-
tions were determined using an automated
colorimetric method based on a modified
Jaffe reaction (Jaffe 1886) on a Beckman
Synchron AS/ASTRA clinical analyzer
(Beckman Instruments, Inc., Brea, CA) at
the Fairview University Medical Center,
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Figure 1. The general metabolism of O,O-diethyl OP pesticides using diazinon as a model. The metabolites
enclosed in boxes are excreted in urine.
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Minneapolis, Minnesota. Samples collected
for OP pesticide measurements were shipped
on dry ice to the CDC’s National Center
for Environmental Health. Urine samples
were analyzed for DAP metabolites of OP
pesticides using the method of Bravo et al.
(2002). Briefly, 4 mL of urine was spiked
with an isotopically labeled internal standard
mixture and concentrated to dryness using an
azeotropic codistillation with acetonitrile.
The residue was dissolved in acetonitrile,
and the DAPs were derivatized to their res-
pective chloropropyl esters using 1-chloro-
3-iodopropane and potassium carbonate.
The solution containing the chloropropyl
esters was concentrated and then analyzed
using gas chromatography–positive chemical
ionization–tandem mass spectrometry.
The DAP metabolites were quantified using
isotope-dilution calibration. Metabolite
concentrations were adjusted using creatinine
concentrations to correct for variable urine
dilutions in the “spot” urine samples. Quality
control materials were analyzed in parallel
with unknown samples. Data were not
reported for sample runs in which the quality
control materials failed to meet the speciﬁca-
tions outlined in the Westgard multirules
(Westgard 2002). Both laboratories and meth-
ods were certiﬁed according to guidelines set
Table 1. Weighted quantiles of urinary DAP concentrations (µg/L) in the NHANES 1999–2000 study population.
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 25th 50th 75th 90th 95th
DMP
Alla 1,949 53 NC < LOD 0.74 2.80 7.90 13.0
(< LOD–1.30) (2.10–3.90) (5.90–9.50) (9.50–21.0)
6–11 years of age 471 63 NC < LOD 1.00 4.40 10.0 21.0
(0.59–2.00) (2.90–6.80) (6.60–18.0) (10.0–41.0)
12–19 years of age 664 50 NC < LOD 0.65 3.80 9.90 22.0
(< LOD–1.50) (2.40–5.50) (6.10–18.0) (12.0–29.0)
20–59 years of age 814 52 NC < LOD 0.68 2.60 6.50 9.70
(< LOD–1.20) (1.80–3.60) (5.2–8.8) (8.50–16.0)
Males 952 53 NC < LOD 0.65 2.80 7.90 18.0
(< LOD–1.20) (2.10–4.10) (5.90–10.0) (9.00–25.0)
Females 997 54 NC < LOD 0.78 2.80 7.60 10.0
(< LOD–1.40) (2.00–4.00) (5.40–9.50) (8.50–15.0)
Non-Hispanic whites 594 49 NC < LOD < LOD 2.90 7.90 10.0
(1.80–4.20) (5.50–9.60) (8.90–21.0)
Non-Hispanic blacks 509 62 NC < LOD 0.98 3.60 8.90 21.0
(0.65–1.30) (2.40–5.50) (6.50–15.0) (12.0–24.0)
Mexican Americans 672 59 NC < LOD 1.00 3.80 9.50 15.0
(< LOD–1.60) (2.70–4.70) (6.80–13.0) (10.0–23.0)
DMTP
Alla 1,949 64 1.82 < LOD 2.70 10.0 38.0 46.0
(1.43–2.32) (1.50–3.80) (8.00–16.0) (21.0–38.0) (38.0–60.0)
6–11 years of age 471 69 2.72 < LOD 4.10 20.0 40.0 62.0
(1.85–4.01) (2.30–7.60) (13.0–30.0) (38.0–54.0) (38.0–110)
12–19 years of age 664 67 2.53 < LOD 3.60 16.0 37.0 69.0
(1.72–3.63) (1.70–6.00) (8.80–24.0) (21.0–38.0) (39.0–190)
20–59 years of age 814 63 1.59 < LOD 2.20 9.10 38.0 38.0
(1.25–2.03) (1.10–3.40) (7.10–13.0) (18.0–38.0) (38.0–48.0)
Males 952 66 2.10 < LOD 3.40 13.0 38.0 41.0
(1.58–2.78) (2.40–4.50) (8.50–20.0) (17.0–38.0) (38.0–62.0)
Females 997 62 1.59 < LOD 2.00 9.70 38.0 52.0
(1.2–2.11) (0.72–3.30) (6.70–16.0) (19.0–38.0) (38.0–120)
Non-Hispanic whites 594 64 1.77 < LOD 2.60 10.0 37.0 45.0
(1.30–2.39) (1.10–4.00) (7.00–17.0) (15.0–38.0) (38.0–62.0)
Non-Hispanic blacks 509 68 2.13 < LOD 3.60 11.0 37.0 39.0
(1.38–3.28) (1.60–5.60) (8.30–18.0) (25.0–38.0) (38.0–88.0)
Mexican Americans 672 63 1.79 < LOD 2.00 10.0 38.0 130
(1.11–2.90) (0.60–4.30) (6.60–16.0) (26.0–79.0) (41.0–230)
DMDTP
Alla 1,949 53 NC < LOD < LOD 2.30 12.0 19.0
(1.40–3.60) (5.40–17.0) (17.0–37.0)
6–11 years of age 471 63 NC < LOD < LOD 4.30 16.0 32.0
(2.50–6.90) (5.90–18.0) (18.0–38.0)
12–19 years of age 664 51 NC < LOD < LOD 2.20 12.0 19.0
(1.30–4.50) (6.20–17.0) (12.0–52.0)
20–59 years of age 814 48 NC < LOD < LOD 2.10 10.0 16.0
(1.10–3.10) (4.20–17.0) (6.30–19.0)
Males 952 53 NC < LOD < LOD 2.30 16.0 18.0
(1.30–4.30) (5.80–17.0) (17.0–32.0)
Females 997 53 NC < LOD < LOD 2.10 10.0 20.0
(1.30–3.20) (4.50–17.0) (13.0–40.0)
Non-Hispanic whites 594 50 NC < LOD < LOD 2.00 13.0 18.0
(0.850–3.70) (4.20–17.0) (16.0–40.0)
Non-Hispanic blacks 509 56 NC < LOD < LOD 3.20 14.0 18.0
(1.70–6.50) (7.0–18.0) (17.0–39.0)
Mexican Americans 672 53 NC < LOD < LOD 1.80 5.70 12.0
(1.20–2.30) (4.00–9.70) (6.80–17.0)
Continued, next pageforth in the Clinical Laboratory Improvement
Amendment (1988).
Covariates. Age was reported at the time
of the household interview as the age in years
at the last birthday. Age categories used in
our statistical analyses were 6–11 years,
12–19 years, and 20–59 years. A composite
racial/ethnic variable based on self-reported
race and ethnicity was created to deﬁne three
major racial/ethnic groups: non-Hispanic
black, non-Hispanic white, and Mexican
American. Individuals from other racial/eth-
nic groups were included in the total esti-
mates reported in this publication; however,
no separate demographic breakdown was
provided.
Traditionally, creatinine concentrations
have been used to adjust spot urine samples
for variable dilution caused by the different
hydration states of the sample donor. Because
age group, sex, and race/ethnicity all affect the
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Table 1. Continued
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 25th 50th 75th 90th 95th
DEP
Alla 1,949 71 1.03 < LOD 1.20 3.10 7.50 13.0
(0.76–1.40) (0.80–1.50) (2.40–4.60) (5.20–11.0) (8.00–21.0)
6–11 years of age 471 74 1.32 < LOD 1.40 4.50 10.0 15.0
(0.85–2.05) (0.99–2.10) (2.30–6.50) (4.80–16.0) (11.0–27.0)
12–19 years of age 664 73 1.21 < LOD 1.30 3.70 7.90 20.0
(0.85–1.72) (1.00–1.90) (2.40–5.40) (4.20–23.0) (8.00–27.0)
20–59 years of age 814 69 0.955 < LOD 1.00 3.00 7.20 10.0
(0.70–1.30) (0.73–1.40) (2.10–4.40) (4.90–10.0) (6.90–19.0)
Males 952 72 1.11 < LOD 1.10 3.80 8.00 18.0
(0.81–1.54) (0.85–1.40) (2.50–4.90) (5.00–19.00) (7.40–27.0)
Females 997 69 0.954 < LOD 1.10 2.90 7.50 11.0
(0.69–1.32) (0.73–1.50) (2.10–4.40) (4.90–10.0) (7.70–14.0)
Non-Hispanic whites 594 68 0.98 < LOD 1.10 3.30 7.60 14.0
(0.67–1.44) (0.58–1.50) (2.30–4.90) (4.80–14.0) (7.90–23.0)
Non-Hispanic blacks 509 82 1.56 < LOD 1.60 4.20 10.0 18.0
(1.23–1.98) (1.30–1.80) (2.90–5.80) (6.20–16.0) (10.0–26.0)
Mexican Americans 672 74 1.22 < LOD 1.10 4.10 11.00 17.0
(0.87–1.71) (0.84–1.50) (2.60–6.40) (6.90–13.0) (12.0–23.0)
DETP
Alla 1,949 53 NC < LOD 0.49 0.76 1.30 2.20
(< LOD–0.62) (0.66–0.91) (1.20–1.60) (1.70–2.80)
6–11 years of age 471 59 NC < LOD 0.59 0.90 1.70 3.13
(< LOD–0.72) (0.73–1.20) (1.30–2.40) (1.70–5.00)
12–19 years of age 664 46 NC < LOD 0.21 0.78 1.40 2.20
(< LOD–0.64) (0.63–1.20) (1.20–1.90) (1.60–3.10)
20–59 years of age 814 54 NC < LOD 0.480 0.74 1.30 2.00
(< LOD–0.59) (0.63–0.91) (0.99–1.50) (1.50–2.80)
Males 952 57 NC < LOD 0.50 0.79 1.40 2.70
(< LOD–0.630) (0.70–1.00) (1.20–1.90) (1.90–4.10)
Females 997 50 NC < LOD < LOD 0.72 1.24 1.70
(0.600–0.910) (0.950–1.50) (1.30–2.70)
Non-Hispanic whites 594 51 NC < LOD 0.16 0.73 1.30 1.80
(< LOD–0.63) (0.60–1.00) (0.980–1.50) (1.50–2.80)
Non-Hispanic blacks 509 64 NC < LOD 0.56 0.81 1.80 3.50
(< LOD–0.670) (0.69–1.20) (1.24–3.30) (1.80–4.80)
Mexican Americans 672 58 NC < LOD 0.56 0.84 1.40 2.20
(< LOD–0.70) (0.74–0.98) (1.10–1.90) (1.90–2.90)
DEDTP
Alla 1,949 56 NC < LOD 0.08 0.20 0.47 0.87
(< LOD–0.11) (0.15–0.29) (0.39–0.63) (0.65–1.00)
6–11 years of age 471 60 NC < LOD 0.08 0.19 0.43 0.85
(< LOD–0.11) (0.15–0.24) (0.30–0.55) (0.49–1.00)
12–19 years of age 664 50 NC < LOD 0.08 0.26 0.64 0.90
(< LOD–0.11) (0.12–0.35) (0.36–0.86) (0.68–1.30)
20–59 years of age 814 56 NC < LOD 0.08 0.21 0.45 0.90
(< LOD–0.11) (0.13–0.29) (0.36–0.62) (0.61–1.10)
Males 952 57 NC < LOD 0.09 0.22 0.47 0.87
(< LOD–0.10) (0.16–0.29) (0.36–0.66) (0.65–1.10)
Females 997 54 NC < LOD 0.08 0.19 0.45 0.85
(< LOD–0.10) (0.11–0.30) (0.35–0.69) (0.46–1.40)
Non-Hispanic whites 594 53 NC < LOD 0.08 0.19 0.42 0.87
(< LOD–0.12) (0.12–0.28) (0.32–0.68) (0.51–1.10)
Non-Hispanic blacks 509 61 NC < LOD 0.09 0.27 0.56 0.85
(< LOD–0.11) (0.18–0.33) (0.42–0.82) (0.65–1.20)
Mexican Americans 672 66 NC < LOD 0.10 0.31 0.65 1.10
(0.07–0.15) (0.23–0.39) (0.49–1.00) (0.63–1.70)
Abbreviations: GM. geometric mean; LOD, limit of detection; NC, not calculated because proportion of results below the LOD was too high to provide reliable result; NE, could not be reliably
estimated. Upper and lower 95th conﬁdence intervals of each quantile are shown in parentheses; these data are shown as total population data and divided into demographic subgroups
based on race/ethnicity, sex, and age.
aAll population data, including those individuals not grouped into one of the three composite race/ethnicity categories, are presented.creatinine concentrations in the urine, creati-
nine adjustment in diverse populations would
not be valid for comparisons of DAP concen-
trations among the demographic groups. To
overcome this limitation and thereby allow
for an appropriate comparison of DAP con-
centrations among the demographic groups,
creatinine was also used as a covariate in sta-
tistical models. By using this model for DAP
concentration comparisons, we appropriately
corrected for covariate effects on the creati-
nine concentrations while eliminating the
variability caused by urine dilution of spot
samples.
Statistical analysis. Survey-speciﬁc sample
weights tailored to suit the random subset
were used in statistical analyses. Parametric
statistics were performed only on analytes for
which the frequency of detection was greater
than or equal to 60%. Geometric means
(GMs), least-squares geometric means
(LSGMs), and percentiles of urinary DAP
concentrations were calculated using SAS soft-
ware release 8 (SAS Institute, Cary, NC) and
SUDAAN software release 7.5.6 (Research
Triangle Institute, Research Triangle Park,
NC). LSGMs are GMs that have been calcu-
lated using an analysis of covariance. The ana-
lytic limits of detection (LODs; defined as
three times the standard deviation at zero
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Table 2. Weighted quantiles of creatinine-adjusted urinary DAP concentrations (µg/g creatinine) in the NHANES 1999–2000 study population.
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 25th 50th 75th 90th 95th
DMP
Alla 1,949 53 NC < LOD 0.81 2.93 8.46 16.1
(0.59–1.11) (2.12–3.86) (6.74–11.2) (12.1–19.5)
6–11 years of age 471 63 NC < LOD 1.38 4.48 15.9 21.7
(0.89–2.38) (2.63–8.20) (7.65–21.7) (16.7–45.1)
12–19 years of age 664 50 NC < LOD 0.59 2.27 7.70 14.5
(0.45–0.95) (1.67–2.91) (4.16–13.8) (7.78–35.3)
20–59 years of age 814 52 NC < LOD 0.76 2.87 8.11 14.6
(0.56–1.11) (1.91–3.92) (5.45–10.6) (10.1–17.6)
Males 952 53 NC < LOD 0.62 2.38 7.58 15.2
(0.45–0.89) (1.78–3.23) (4.64–11.6) (9.74–19.5)
Females 997 54 NC < LOD 1.00 3.53 9.12 16.4
(0.68–1.50) (2.35–5.00) (7.59–12.2) (10.4–21.4)
Non-Hispanic whites 594 49 NC < LOD < LOD 3.15 8.73 15.8
(2.03–4.26) (6.12–12.8) (10.2–19.7)
Non-Hispanic blacks 509 62 NC < LOD 0.69 2.67 7.07 13.9
(0.53–1.06) (1.78–3.87) (4.77–11.5) (9.61–19.5)
Mexican Americans 672 59 NC < LOD 1.06 3.68 9.41 15.9
(0.72–1.47) (2.77–4.67) (7.24–12.2) (12.7–23.2)
DMTP
Alla 1,949 64 1.64 < LOD 2.12 9.57 32.0 51.0
(1.27–2.10) (1.38–3.11) (6.67–15.1) (23.9–40.4) (39.0–71.1)
6–11 years of age 471 69 2.95 < LOD 5.25 18.7 45.2 65.9
(2.00–4.34) (2.50–7.03) (11.6–31.5) (32.1–60.3) (50.7–100)
12–19 years of age 664 67 1.71 < LOD 2.14 13.4 36.0 61.5
(1.13–2.59) (1.22–4.13) (7.01–21.0) (25.1–51.4) (37.1–179)
20–59 years of age 814 63 1.47 < LOD 1.90 8.09 27.0 47.4
(1.14–1.90) (1.00–2.83) (5.58–12.4) (20.6–37.1) (34.2–70.1)
Males 952 66 1.61 < LOD 2.28 9.27 28.9 41.1
(1.19–2.18) (1.42–3.35) (6.43–15.4) (20.5–37.6) (32.0–57.1)
Females 997 62 1.66 < LOD 2.01 10.0 34.5 69.5
(1.24–2.21) (0.92–3.11) (6.20–17.5) (25.4–47.4) (41.7–118)
Non-Hispanic whites 594 64 1.68 < LOD 2.20 9.27 32.5 54.4
(1.21–2.32) (1.17–3.42) (5.96–16.9) (21.3–49.4) (39.2–74.7)
Non-Hispanic blacks 509 68 1.45 < LOD 1.75 8.21 25.5 52.1
(0.95–2.23) (1.01–3.38) (4.65–12.4) (17.9–38.8) (25.5–97.6)
Mexican Americans 672 63 1.60 < LOD 1.83 10.4 37.0 112
(0.962–2.67) (0.74–3.75) (5.93–17.1) (22.8–63.1) (39.2–207)
DMDTP
Alla 1,949 53 NC < LOD < LOD 1.86 10.1 21.7
(1.04–3.25) (5.63–16.6) (13.8–30.8)
6–11 years of age 471 63 NC < LOD < LOD 4.07 16.2 30.8
(2.34–7.00) (9.25–27.0) (20.2–38.9)
12–19 years of age 664 51 NC < LOD < LOD 1.52 9.42 18.5
(0.64–3.37) (4.02–16.8) (8.76–44.8)
20–59 years of age 814 48 NC < LOD < LOD 1.71 8.46 19.2
(0.92–2.82) (4.96–16.6) (9.82–35.2)
Males 952 53 NC < LOD < LOD 1.64 11.0 17.8
(0.87–3.45) (5.32–16.6) (10.1–34.2)
Females 997 53 NC < LOD < LOD 1.99 9.30 27.0
(1.00–3.67) (5.41–21.5) (9.82–47.5)
Non-Hispanic whites 594 50 NC < LOD < LOD 1.75 11.3 21.5
(0.85–4.00) (4.79–20.2) (12.8–30.8)
Non-Hispanic blacks 509 56 NC < LOD < LOD 2.39 9.41 17.8
(1.18–4.53) (5.11–16.6) (11.6–36.0)
Mexican Americans 672 53 NC < LOD < LOD 1.35 6.55 16.7
(0.97–1.99) (4.10–11.6) (6.94–34.2)
Continued, next pageconcentration) were 0.58 µg/L for DMP,
0.18 µg/L for DMTP, 0.08 µg/L for DMDTP,
0.2 µg/L for DEP, 0.09 µg/L for DETP, and
0.05 µg/L for DEDTP. For concentrations
below the LODs, a value equal to the LOD
divided by the square root of 2 was used
(Hornung and Reed 1990). For the statistical
analyses of summed metabolite concentra-
tions, the individual metabolite concentra-
tions in units of micrograms per liter or
micrograms per gram creatinine were con-
verted to their nanomolar units using the gen-
eral formula (analyte concentration/molecular
weight of analyte) × 1,000, giving final
concentrations in units of nanomoles per liter
or nanomoles per gram creatinine, respec-
tively. SUDAAN incorporates the NHANES
sampling weights and adjusts for the complex
sample design of the survey. Sample weights
take into account nonresponse and the
unequal probabilities of selection, resulting
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Table 2. Continued
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 25th 50th 75th 90th 95th
DEP
Alla 1,949 71 0.93 < LOD 0.92 2.73 7.94 12.1
(0.69–1.25) (0.63–1.28) (1.89–4.29) (4.90–11.7) (8.75–17.5)
6–11 years of age 471 74 1.43 < LOD 1.47 3.94 10.3 16.2
(0.94–2.17) (1.02–2.41) (2.39–8.15) (4.55–20.6) (10.5–32.7)
12–19 years of age 664 73 0.76 < LOD 0.79 2.29 5.38 12.3
(0.55–1.05) (0.62–1.13) (1.40–3.42) (2.89–12.3) (4.87–23.8)
20–59 years of age 814 69 0.90 < LOD 0.86 2.63 7.37 12.1
(0.67–1.23) (0.58–1.18) (1.71–4.38) (4.60–11.3) (8.57–15.7)
Males 952 72 0.86 < LOD 0.81 2.61 7.69 12.2
(0.63–1.17) (0.59–1.19) (1.76–4.13) (4.55–11.7) (8.00–21.6)
Females 997 69 1.00 < LOD 0.96 2.80 8.00 12.1
(0.73–1.37) (0.64–1.45) (1.89–4.72) (4.90–11.7) (8.10–17.5)
Non-Hispanic whites 594 68 0.94 < LOD 0.90 2.82 8.46 12.6
(0.65–1.37) (0.51–1.48) (1.75–5.33) (4.95–13.3) (8.89–19.6)
Non-Hispanic blacks 509 82 1.06 < LOD 1.17 2.55 5.98 11.7
(0.84–1.35) (0.83–1.53) (2.13–3.24) (4.22–8.93) (6.62–19.4)
Mexican Americans 672 74 1.08 < LOD 1.05 3.78 9.84 15.6
(0.74–1.58) (0.74–1.57) (2.29–5.79) (6.57–14.4) (10.3–19.3)
DETP
Alla 1,949 53 NC < LOD 0.25 0.71 1.70 2.64
(0.10–0.42) (0.51–0.96) (1.21–2.17) (2.12–2.96)
6–11 years of age 471 59 NC < LOD 0.47 1.08 1.73 2.45
(0.15–0.83) (0.83–1.30) (1.44–2.36) (1.88–5.42)
12–19 years of age 664 46 NC < LOD 0.18 0.51 1.07 1.97
(0.06–0.33) (0.34–0.76) (0.78–1.53) (1.07–3.92)
20–59 years of age 814 54 NC < LOD 0.25 0.69 1.79 2.75
(0.10–0.41) (0.47–0.96) (1.18–2.32) (2.12–3.06)
Males 952 57 NC < LOD 0.27 0.67 1.34 2.66
(0.10–0.42) (0.52–0.81) (1.08–2.18) (1.56–3.23)
Females 997 50 NC < LOD < LOD 0.79 1.89 2.52
(0.45–1.20) (1.22–2.33) (2.08–2.96)
Non-Hispanic whites 594 51 NC < LOD 0.23 0.71 1.88 2.58
(0.08–0.46) (0.46–1.05) (1.20–2.36) (2.12–2.96)
Non-Hispanic blacks 509 64 NC < LOD 0.30 0.72 1.35 2.89
(0.15–0.46) (0.54–0.84) (0.90–2.89) (1.35–5.13)
Mexican Americans 672 58 NC < LOD 0.34 0.83 1.69 2.71
(0.10–0.57) (0.57–1.13) (1.30–2.16) (1.86–3.55)
DEDTP
Alla 1,949 56 NC < LOD 0.07 0.20 0.55 0.86
(0.06–0.11) (0.15–0.26) (0.41–0.69) (0.69–1.13)
6–11 years of age 471 60 NC < LOD 0.10 0.19 0.57 1.03
(0.07–0.13) (0.15–0.25) (0.39–0.77) (0.60–1.57)
12–19 years of age 664 50 NC < LOD 0.05 0.17 0.44 0.73
(0.04–0.07) (0.10–0.22) (0.23–0.73) (0.39–0.95)
20–59 years of age 814 56 NC < LOD 0.08 0.21 0.55 0.86
(0.06–0.11) (0.15–0.29) (0.38–0.71) (0.67–1.16)
Males 952 57 NC < LOD 0.07 0.19 0.42 0.72
(0.05–0.10) (0.14–0.22) (0.32–0.52) (0.49–0.94)
Females 997 54 NC < LOD 0.09 0.22 0.67 0.89
(0.06–0.12) (0.16–0.32) (0.41–0.86) (0.71–1.38)
Non-Hispanic whites 594 53 NC < LOD 0.07 0.20 0.55 0.88
(0.05–0.11) (0.14–0.29) (0.39–0.73) (0.65–1.16)
Non-Hispanic blacks 509 61 NC < LOD 0.07 0.18 0.45 0.69
(0.05–0.10) (0.13–0.22) (0.28–0.68) (0.48–1.07)
Mexican Americans 672 66 NC < LOD 0.09 0.30 0.81 1.16
(0.07 –0.15) (0.19–0.41) (0.52–1.00) (0.86–2.66)
Abbreviations: GM. geometric mean; LOD, limit of detection; NC, not calculated because proportion of results below the LOD was too high to provide reliable result; NE, could not be reliably
estimated. Upper and lower 95th conﬁdence intervals of each quantile are shown in parentheses; these data are shown as total population data and divided into demographic subgroups
based on race/ethnicity, sex, and age.
aAll population data, including those individuals not grouped into one of the three composite race/ethnicity categories, are presented.from the cluster design and the planned over-
sampling of certain subgroups.
The LSGMs for each demographic group
were corrected for effects of all covariates,
including creatinine. Differences in LSGMs
among demographic groups were considered
significant when p < 0.05 and nominally or
marginally signiﬁcant when p > 0.05 but < 0.1.
Results
Our data included 1,949 valid concentrations
for each DAP in urine samples collected
during 1999 and 2000. The distribution of
the DAP metabolites in the NHANES sam-
ples analyzed are presented in Table 1. These
values are presented as volume-based concen-
trations to allow for comparisons with similar
data in the literature. The creatinine-adjusted
concentrations are shown in Table 2. The
volume-based and creatinine-adjusted GMs
for each demographic group are shown graph-
ically in Figure 2. DEP was detected with the
highest frequency in about 70% of the sam-
ples tested; however, DMTP was detected in
the highest concentrations. Concentrations of
DEP and DETP in individual samples were
highly correlated (r = 0.66, p < 0.0001), sug-
gesting they were derived from a common
source, such as chlorpyrifos or diazinon. No
other DAPs were correlated.
The LSGMs for each demographic group
are shown in Table 3. For all analytes, chil-
dren 6–11 years of age had higher concentra-
tions, even after correcting for all covariates
including creatinine. Children 6–11 years of
age had a signiﬁcantly higher LSGM concen-
tration of DEP than did adults (p = 0.008) but
only marginally signiﬁcantly higher concentra-
tion than did adolescents (p = 0.07). Children
had a significantly higher LSGM concentra-
tion of DMTP than did adults (p = 0.015),
but the difference between values for children
and adolescents was not signiﬁcant.
All DAPs were detected more frequently
in Mexican Americans and non-Hispanic
blacks than in non-Hispanic whites, although
the differences were not signiﬁcant. Mexican
Americans had higher concentrations of
DEP and DEDTP, whereas non-Hispanic
blacks had higher concentrations of DMP
and DETP. Mexican Americans and non-
Hispanic whites had higher concentrations of
DMTP than did non-Hispanic blacks, and
all groups had similar concentrations of
DMDTP. The maximum concentrations
observed for the DAPs were more frequently
seen in Mexican Americans. None of the
differences observed among the racial/ethnic
groups was signiﬁcant.
Because the methyl-containing metabolites
are derived from O,O-dimethyl–substituted
OP pesticides such as azinphos-methyl and
malathion, their concentrations were converted
to molar equivalents and summed to produce
one composite dimethyl alkylphosphate
(DMAP) concentration for each person. A
similar conversion and summation was per-
formed for the ethyl-containing metabolites
[diethyl alkylphosphate (DEAP) composite].
The distributions of the composite DMAP and
DEAP concentrations in the NHANES sam-
ples analyzed are presented in Table 4. These
values are presented as volume-based molar
concentrations to allow for comparisons with
similar data in the literature. The creatinine-
adjusted concentrations are shown in Table 5.
The volume-based and creatinine-adjusted
GMs for each demographic group are shown
graphically in Figure 3. The LSGMs are given
in Table 3.
Children 6–11 years of age had signifi-
cantly higher concentrations of both DMAP
and DEAP than did adults (both p < 0.007).
Although these concentrations were also higher
Article | Barr et al.
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Figure 2. DAP GMs for each demographic group. (A) Volume-based and (B) creatinine-adjusted concentrations. For clarity of presentation, the upper and lower
conﬁdence intervals are not shown here but are given in Tables 1 and 2. 
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Table 3. LSGMs (95% CIs) of urinary DAP metabolites among demographic groups.
Category Demographic group DMTP (µg/L) DEP (µg/L) DMAP (nmol/L) DEAP (nmol/L) DAP (nmol/L)
Age 6–11 years of age (children) 3.08* 1.73* 72.8* 17.4* 109.6*
(1.90–4.97) (1.06–2.83) (54.3–97.5) (11.1–27.3) (83.3–144.3)
12–19 years of age (adolescents) 2.07 1.06 56.9 11.0 89.3*
(1.35–3.17) (0.73–1.55) (40.2–80.7) (7.6–15.9) (65.2–122.2)
20–59 years of age (adults) 1.59 1.00 42.1 10.0 66.9
(1.16–2.16) (0.74–1.37) (33.6–52.8) (7.5–13.2) (54.3–82.5)
Sex Males 2.00 1.08 50.6 10.8 79.1
(1.44–2.78) (0.79–1.49) (40.0–64.2) (8.0–14.5) (62.6–99.9)
Females 1.57 1.07 42.9 10.7 68.2
(1.11–2.22) (0.77–1.48) (33.8–54.3) (8.0–14.3) (55.9–83.3)
Race/ethnicity Non-Hispanic whites 1.78 1.03 45.2 10.4 70.9
(1.25–2.53) (0.73–1.47) (35.3–57.8) (7.5–14.3) (56.4–89.1)
Non-Hispanic blacks 1.79 1.25 53.0 12.0 83.0
(1.15–2.79) (0.98–1.60) (38.8–72.6) (9.3–15.5) (65.6–105.0)
Mexican Americans 1.69 1.16 50.1 12.2 82.7
(1.02–2.80) (0.80–1.70) (36.8–68.3) (8.6–17.2) (62.1–110.2)
LSGMs were adjusted for age, sex, race/ethnicity, and concentrations of serum cotinine and urinary creatinine. LSGMs were calculated for metabolites with detection frequencies
of ≥ 60%.
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than for adolescents, the differences were not
significant for DMAP (p = 0.26) and only
marginally significant for DEAP (p = 0.06).
Adolescents had higher concentrations of
DMAP than did adults, but the difference
was only marginally significant (p = 0.08).
The total DAP concentrations in children
and adolescents were also signiﬁcantly greater
than in adults (p < 0.0001).
Although we report only the DAP concen-
trations, four “selective” metabolites of OP
pesticides were also measured in the same sam-
ples. These selective metabolites are derived
from the organic portion of the pesticide that is
unique to a specific OP pesticide or diethyl/
dimethyl congener pair. The selective metabo-
lites we measured and their parent pesticides
are listed in Table 6. Although the distribution
data will be reported elsewhere (Barr et al.
Unpublished data), we used a Pearson correla-
tion analysis to examine the correlation of the
Table 4. Weighted quantiles of composite DMAP and DEAP concentrations (nmol/L) in the NHANES 1999–2000 study population.
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 10th 25th 50th 75th 90th 95th
DAP
Alla 1,949 94 76.3 8.65 31.1 81.7 202 399 651
(65.0–89.6) (6.00–15.2) (24.0–40.0) (65.5–98.9) (168–270) (357–475) (516–911)
6–11 years of age 471 96 101 10.6 40.3 113 287 507 832
(80.7–126) (6.00–22.0) (26.5–61.0) (78.2–152) (218–350) (410–623) (599–1,230)
12–19 years of age 664 94 96.5 12.9 36.0 93.2 268 541 1,130
(73.6–127) (6.50–21.9) (28.0–50.2) (64.3–135) (175–320) (362–1,000) (563–2,180)
20–59 years of age 814 92 69.4 7.36 26.6 75.3 188 380 552
(58.5–82.4) (6.00–12.8) (20.0–39.6) (60.3–92.5) (144–233) (294–416) (411–798)
Males 952 94 82.9 11.2 35.7 87.1 239 400 648
(67.5–101.8) (6.40–19.4) (26.4–47.0) (65.4–110) (164–288) (332–520) (486–930)
Females 997 93 70.4 6.46 25.0 76.2 190 387 692
(60.0–82.6) (6.00–12.5) (19.6–36.0) (61.6–92.3) (152–227) (300–454) (428–971)
Non-Hispanic whites 594 92 72.8 6.51 27.5 76.2 202 386 651
(59.0–90.0) (6.00–12.4) (19.4–41.0) (60.7–107) (151–273) (314–494) (471–932)
Non-Hispanic blacks 509 96 96.3 18.1 43.4 105 233 417 692
(79.1–117) (12.0–26.8) (32.0–56.8) (78.1–123) (171–278) (330–623) (481–911)
Mexican Americans 672 93 84.1 10.5 32.2 81.7 215 479 1,250
(65.0–109) (6.00–20.7) (24.4–43.0) (59.7–114) (172–264) (347–798) (532–1,930)
DMAP
Alla 1,949 84 49.4 4.47 13.2 54.5 159 377 583
(41.7–58.5) (4.20–4.55) (7.60–19.5) (42.2–68.8) (123–216) (290–403) (441–725)
6–11 years of age 471 87 70.3 4.47 23.4 90.6 270 460 679
(55.6–88.8) (4.20–4.55) (11.8–39.0) (64.9–112) (174–308) (338–515) (493–1,080)
12–19 years of age 664 84 63.0 4.55 18.1 62.2 224 472 1,120
(46.8–84.7) (4.20–4.55) (11.6–28.0) (41.2–103) (139–271) (320–911) (498–2,140)
20–59 years of age 814 82 44.3 4.55 11.8 48.3 137 331 426
(36.9–53.1) (4.20–4.55) (6.10–18.4) (37.4–62.4) (102–181) (271–378) (379–623)
Males 952 84 53.1 4.55 17.2 59.1 179 377 552
(43.2–65.2) (4.20–4.55) (11.6–24.0) (45.1–74.5) (117–271) (288–419) (378–725)
Females 997 84 46.0 4.55 11.0 46.8 149 375 638
(38.2–55.5) (4.20–4.55) (4.80–18.0) (37.7–68.7) (116–179) (274–414) (401–937)
Non-Hispanic whites 594 82 47.3 4.15 11.6 54.0 153 366 568
(37.9–59.0) (4.20–4.55) (5.4–21.9) (38.4–70.2) (112–237) (273–409) (394–783)
Non-Hispanic blacks 509 86 59.6 4.55 22.3 71.9 195 379 623
(44.9–79.0) (4.20–4.55) (10.0–37) (50.3–96.3) (121–268) (292–469) (421–812)
Mexican Americans 672 84 52.1 4.15 15.6 48.0 155 403 1,230
(39.1–69.4) (4.20–4.55) (7.10–24.6) (38.6–72.0) (124–189) (271–748) (455–1,920)
DEAP
Alla 1,949 77 10.5 < LOD 2.30 12.3 28.3 64.7 108
(7.93–13.9) (1.50–7.20) (9.9–15.6) (22.0–36.6) (42.9–84.7) (73.4–147)
6–11 years of age 471 80 13.2 < LOD 4.70 15.6 35.9 87.5 136
(8.80–19.8) (1.50–11.7) (12.3–21.4) (21.2–60.3) (51.3–121) (87.2–200)
12–19 years of age 664 82 11.8 < LOD 3.23 12.9 30.5 84.4 161
(8.4–16.6) (1.48–8.34) (10.3–16.8) (19.1–45.1) (39.5–164) (64.4–185)
20–59 years of age 814 76 9.85 < LOD 1.80 11.6 27.0 59.0 88.0
(7.46–13.0) (1.48–6.10) (9.12–14.4) (20.5–34.1) (41.8–78.5) (65.9–137)
Males 952 80 11.5 < LOD 2.96 12.4 31.9 68.9 147
(8.60–15.4) (1.48–7.70) (10.0–16.6) (22.0–39.7) (46.4–137) (73.4–186)
Females 997 77 9.56 < LOD < LOD 11.9 25.5 58.4 80.1
(7.10–12.8) (9.00–15.5) (19.1–34.0) (41.7–77.1) (70.6–104)
Non-Hispanic whites 594 76 9.96 < LOD < LOD 12.0 28.0 65.1 109
(7.03–14.1) (7.80–16.5) (19.2–39.9) (41.7–105) (70.6–161)
Non-Hispanic blacks 509 83 15.2 < LOD 9.01 15.7 36.6 77.8 126
(12.1–19.2) (3.23–11.2) (12.5–19.0) (29.2–44.1) (50.5–113) (78.5–186)
Mexican Americans 672 81 12.5 < LOD 3.82 13.9 33.5 83.9 126
(9.10–17.1) (1.48–9.18) (10.9–17.3) (23.1–48.6) (58.4–102) (95.8–178)
NE, could not be reliably estimated. To determine the composite concentrations, the dialkylphosphate concentrations were converted to their molar equivalents and then summed.
Upper and lower 95th conﬁdence intervals of each quantile are shown in parentheses; these data are shown as total population data and divided into demographic subgroups based on
race/ethnicity, sex, and age.
aAll population data, including those individuals not grouped into one of the three composite race/ethnicity categories, are presented.concentrations of these selective pesticides with
their corresponding DAP metabolites. The
results of our analyses are shown in Table 6.
Concentrations of 3,5,6-trichloro-2-pyridinol,
a selective metabolite of chlorpyrifos and chlor-
pyrifos-methyl, were significantly correlated
with both DEP (r = 0.22, p < 0.0001) and
DETP (r = 0.29, p < 0.0001) concentrations.
Likewise, concentrations of IMPY, a selective
metabolite of diazinon, were signiﬁcantly cor-
related with both DEP (r = 0.27, p < 0.0001)
and DETP (r = 0.38, p < 0.0001) concentra-
tions. Other signiﬁcant, albeit weak, correla-
tions were seen among the other metabolites
tested. Similar correlations were observed
among the selective metabolites and the com-
posite DEAP and DMAP variables.
Discussion
We report concentrations of DAPs in the U.S.
population using several different formats to
Article | Barr et al.
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Table 5. Weighted quantiles of creatinine-adjusted composite DMAP and DEAP concentrations (nmol/L) in the NHANES 1999–2000 study population.
Analyte/ Detection Percentile of distribution
demographic category No. frequency (%) GM 10th 25th 50th 75th 90th 95th
DAP
Alla 1,949 94 68.5 10.0 25.9 70.9 189 405 748
(57.98–80.92) (8.10–12.5) (19.0–34.6) (55.5–84.6) (152–223) (310–493) (536–1,000)
6–11 years of age 471 96 109 14.9 41.3 116 283 574 979
(88.7–134.1) (10.8–24.2) (28.4–63.2) (95.1–159) (205–351) (364–905) (609–1,240)
12–19 years of age 664 94 65.1 9.42 22.0 57.1 170 432 1,120
(48.96–86.67) (7.90–13.5) (15.0–33.0) (40.0–87.0) (115–227) (252–880) (500–1,470)
20–59 years of age 814 92 64.1 9.42 23.9 67.8 176 352 611
(53.33–77.06) (7.5–11.9) (17.5–34.2) (51.3–81.0) (139–217) (281–471) (412–1,000)
Males 952 94 63.7 10.2 23.8 64.1 177 352 611
(51.1–79.3) (8.20–12.6) (17.0–35.0) (51.0–82.2) (135–222) (269–452) (409–981)
Females 997 93 73.6 9.99 27.3 78.3 204 438 912
(62.2–87.0) (7.80–12.6) (18.8–35.9) (59.7–92.8) (157–240) (342–566) (538–1,120)
Non-Hispanic whites 594 92 69.2 9.67 25.3 74.2 197 405 713
(55.4–86.5) (7.50–12.3) (16.7–38.2) (54.8–94.2) (146–246) (288–566) (475–1,030)
Non-Hispanic blacks 509 96 65.9 13.7 23.8 62.5 148 336 656
(54.2–80.1) (10.5–17.3) (19.1–31.0) (49.2–76.3) (115–217) (259–540) (423–854)
Mexican Americans 672 93 75.3 10.0 29.5 75.1 180 453 1,130
(56.4–100) (6.33–18.2) (22.1–39.7) (57.1–97.8) (137–261) (290–912) (512–1,460)
DMAP
Alla 1,949 84 44.3 4.14 13.5 43.4 153 337 601
(37.2–52.8) (3.30–5.50) (9.50–19.8) (36.4–56.3) (118–184) (272–408) (414–923)
6–11 years of age 471 87 76.1 5.60 26.5 91.0 243 494 753
(61.0–94.9) (4.40–11.1) (16.4–46.6) (67.4–109) (169–316) (326–683) (499–1,060)
12–19 years of age 664 84 42.5 3.92 10.4 36.7 139 418 961
(30.9–58.5) (2.80–6.40) (7.10–19.0) (27.8–58.9) (103–191) (226–762) (425–1,430)
20–59 years of age 814 82 40.9 3.64 12.9 41.1 143 312 522
(33.9–49.4) (3.20–5.50) (8.40–19.6) (33.8–50.3) (95.7–173) (238–403) (352–822)
Males 952 84 40.8 3.73 13.3 40.4 144 295 472
(32.7–50.9) (3.30–5.10) (9.10–18.9) (34.7–63.0) (103–182) (237–403) (362–692)
Females 997 84 48.1 4.24 14.4 47.3 163 393 768
(39.7–58.3) (3.50–6.10) (9.30–22.7) (36.3–61.1) (114–206) (312–534) (494–1,110)
Non-Hispanic whites 594 82 44.9 3.79 13.8 44.2 159 337 581
(35.5–56.8) (3.20–5.50) (8.60–23.3) (35.8–60.4) (105–196) (249–454) (402–964)
Non-Hispanic blacks 509 86 40.75 5.00 13.6 42.5 122 318 536
(31.3–53.1) (3.20–7.50) (9.00–22.3) (30.9–57.3) (86.6–193) (232–472) (328–713)
Mexican Americans 672 84 46.6 4.14 16.1 41.9 140 410 1,120
(34.1–63.6) (2.50–7.00) (8.90–23.3) (35.6–57.5) (100–187) (241–768) (446–1,460)
DEAP
Alla 1,949 77 14.7 1.33 3.44 8.82 24.0 66.9 97.7
(11.0–19.6) (1.20–1.80) (2.30–4.91) (6.81–11.9) (16.3–35.3) (43.4–85.5) (80.7–120)
6–11 years of age 471 80 21.5 1.65 5.92 14.9 34.4 85.4 128
(15.9–29.0) (1.21–3.66) (2.52–10.7) (10.7–22.4) (21.1–54.6) (56.0–113) (91.8–213)
12–19 years of age 664 82 10.7 1.28 3.20 7.55 19.6 47.1 112
(8.16–14.1) (1.06–1.81) (1.83–4.35) (6.01–10.2) (11.9–27.4) (26.1–110) (44.2–194)
20–59 years of age 814 76 14.0 1.30 3.28 8.42 23.0 65.5 94.3
(11.0–17.7) (1.16–1.82) (2.22–4.78) (6.41–11.5) (15.4–36.3) (43.1–85.3) (77.4–120)
Males 952 80 12.8 1.26 3.12 8.42 23.0 68.0 104
(9.98–16.4) (1.10–1.46) (1.91–4.62) (6.78–11.7) (16.3–34.8) (40.9–86.3) (80.0–129)
Females 997 77 15.7 1.63 3.68 9.15 24.5 65.6 96.4
(12.3–20.1) (1.26–2.21) (2.62–5.28) (6.72–13.4) (15.8–38.0) (43.1–88.4) (69.8–139)
Non-Hispanic whites 594 76 14.7 1.30 3.20 8.60 26.1 73.9 108
(11.0–19.6) (1.11–1.82) (2.20–4.88) (5.90–13.6) (15.4–43.1) (43.1–97.2) (85.3–139)
Non-Hispanic blacks 509 83 13.9 1.59 4.48 10.8 22.8 48.6 84.5
(11.5–16.8) (1.16–3.02) (3.72–6.44) (8.05–13.7) (17.8–28.1) (35.4–70.2) (57.0–153)
Mexican Americans 672 81 15.5 1.32 3.89 10.6 31.9 75.5 110
(11.6–20.6) (1.05–2.12) (2.28–6.78) (7.81–15.8) (20.9–47.9) (58.5–100) (75.5–145)
NE, could not be reliably estimated. To determine the composite concentrations, the DAP concentrations were converted to their molar equivalents and then summed. Upper and lower
95th conﬁdence intervals of each quantile are shown in parentheses; these data are shown as total population data and divided into demographic subgroups based on race/ethnicity,
sex, and age.
aAll population data, including those individuals not grouped into one of the three composite race/ethnicity categories, are presented.allow these data to be more easily compared
with existing data in the literature. We found
that concentrations of the DAPs among the
various demographic subgroups had subtle,
nonsigniﬁcant differences, except for children
6–11 years of age, who had concentrations
consistently signiﬁcantly higher than in adults
and sometimes significantly higher than in
adolescents. We have reported these data both
as volume-based concentrations and as creati-
nine-adjusted concentrations, to attempt to
correct for the variability in urine dilution
among the “spot” samples. However, the
demographic covariates we evaluated also may
affect the urinary concentrations of creatinine,
thus increasing the variability of the data
instead of reducing it. For example, a child
6–11 years of age is likely to have a lower
concentration of creatinine than would an
adult; therefore, a DAP concentration in the
child may be overcorrected when adjusting
for creatinine, producing a DAP concentra-
tion that is falsely elevated compared with
that of an adult with a similar exposure and
uptake. However, this same adjusted mea-
surement may be more indicative of the size-
related dose of the child, assuming that a
urinary creatinine concentration could be
used as a reasonable surrogate for body
weight because it is proportional to lean mus-
cle mass. For these reasons, the creatinine-
adjusted results should be evaluated with
caution. We have studied the effect of demo-
graphic covariates on creatinine in detail;
these results will be published separately
(Barr et al. Unpublished data). For our statis-
tical analyses to evaluate significant differ-
ences in exposures among the subpopulations,
we included creatinine as a covariate to cor-
rect for the effects of the demographic vari-
ables on creatinine. Therefore, the differences
we report for children represent real differ-
ences in exposure, not false differences pro-
duced by creatinine overcorrection. These
differences are likely because of increased
opportunities for exposure based on their
dietary and physical behaviors (Eskenazi et al.
1999; National Research Council 1993).
Although urinary DAPs have been meas-
ured for almost 30 years to evaluate both occu-
pational and incidental exposures (Table 7),
our data are the first population-based 
reference data reported for the United States.
These data were ﬁrst released in summary for-
mat in the CDC’s Second National Report on
Human Exposure to Environmental Chemicals
in January 2003 (CDC 2003b). We observed
higher frequencies of detection (Table 8) and
higher GMs in 1999, the first year (CDC
2001) of the 2-year NHANES cycle than in the
combined 1999–2000 data that we report.
Because of the small sample size and the small
number of primary sampling units included in
any one year of NHANES, there is a high level
of variation in annual estimates. We did not
formally evaluate the statistical signiﬁcance of
trends in DAP metabolites over this time
period, but differences are unlikely to be sta-
tistically significant. Data from additional
NHANES cycles are required to determine
whether exposure levels have declined.
These DAPs also were measured in
urine samples collected in NHANES II
(1976–1980). These data were never released
publicly because of laboratory quality control
issues that were not resolved (Schober S.
Personal communication), but the NHANES
II frequency of detection information and
mean concentration of the detectable values
were reported by Grifﬁth and Duncan (1985).
Those data are not directly comparable with
the data we report here because the analytical
technology used for those analyses was not
sufﬁciently sensitive to detect these metabolites
in more than 12% of the samples tested
(Murphy et al. 1983). The mean DAP concen-
trations for the detectable samples in
NHANES II ranged from 40 to 110 µg/L,
concentrations well in excess of the 95th
percentiles for all of the analytes we report,
except DMTP.
General population DAP data have been
reported for European populations in Italy
(Aprea et al. 1996, 2000) and Germany (Hardt
and Angerer 2000; Heudorf and Angerer
2001; Figure 4). The Italian adult data were
derived from a sample size that was only about
6% (n = 124) of the number of samples we
report. They reported frequencies of detection
ranging from 7% for DEDTP to 99% for
DMTP (LODs ~1 µg/L). Our frequencies of
detection were much higher for DEDTP
(55%; LOD = 0.05 µg/L) and much lower for
DMTP (59%; LOD = 0.18 µg/L). Other DAP
metabolites were detected much less frequently
as well. The GMs of the Italian population
ranged from 13.7 (DEDTP) to 70.7 (DMTP)
nmol/g creatinine, which are equivalent to
2.5–10 µg/g creatinine. Our GMs ranged from
less than the LOD to 2.95 µg/g creatinine in
certain demographic subgroups.
In addition, one study (Aprea et al. 2000)
measured concentrations of DAPs in children
6–7 years of age in a nonagricultural region of
Italy. DAP metabolites were detected in 12%
(DEDTP) to 96% (DMP) of the samples
tested. The GMs ranged from 7.7 (DEDTP)
to 117 (DMP) nmol/g creatinine, which are
equivalent to 1.4–14.7 µg/g creatinine. DAPs
were detected much less frequently in our
population of children (59–74%) for all ana-
lytes except DMDTP, DETP, and DEDTP.
Aprea et al. (2000) found that the DAP con-
centrations of the children in their study were
signiﬁcantly greater than those of an adult ref-
erence population in Italy (Aprea et al. 1996).
Our results are consistent with this ﬁnding.
The German population data were deter-
mined on a small population subset (n = 54;
Hardt and Angerer 2000). Their frequencies of
detection (LODs = 1–5 µg/L) ranged from 2 to
100%, with DMTP being the most frequently
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Figure 3. Composite DAP GMs for each demo-
graphic group. (A) Volume-based and (B) creatinine-
adjusted concentrations. For clarity of presentation,
the upper and lower confidence intervals are not
shown here but are given in Tables 3 and 4. 
Table 6. Pearson correlation coefﬁcients of DAP metabolites of OP pesticides with selective OP metabolites.
TCPY (chlorpyrifos, PNPa (parathion,
chlorpyrifos-methyl) IMPY (diazinon) MAL (malathion) methyl parathion)
Metabolite r-Value p-Value r-Value p-Value r-Value p-Value r-Value p-Value
DMP 0.11 0.007 ND ND 0.10 0.0138 0.16 0.014
DMTP 0.12 0.0101 ND ND 0.16 < 0.0001 0.09 0.015
DEP 0.22 < 0.0001 0.27 < 0.0001 ND ND 0.27 < 0.0001
DETP 0.29 < 0.0001 0.38 < 0.0001 ND ND 0.27 0.0003
DEAP 0.25 < 0.0001 0.29 < 0.0001 ND ND 0.27 < 0.0001
DMAP 0.114 0.009 ND ND 0.14 0.0004 0.064 0.114
Abbreviations: MAL, malathion dicarboxylic acid; ND, not determined; PNP, para-nitrophenol; TCPY, 3,5,6-trichloropyridinol.
The parent pesticides for each selective metabolite are listed below the metabolite. All analyses were weighted and used
log-transformed data.
aPNP can also be derived from exposure to pesticides such as EPN (O-ethyl-4-O-nitrophenyl phenylphosphonothioate)
and other nonpesticide sources such as 4-aminophenol.Article | Barr et al.
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Table 7. DAP concentrations in reported studies. Concentrations shown are mean values unless otherwise indicated; median values shown in parentheses.
Study Study population No. DMP DMTP DMDTP DEP DETP DEDTP DMAP DEAP Findings
Incidental or community-based measures
Grifﬁth and Duncan 1985a General U.S. 6,894 50 µg/L 60 µg/L 50 µg/L 40 µg/L 40 µg/L 110 µg/L NA NA Low frequency
(NHANES II: of detection
1976–1980)
Aprea et al. 1996b,c Italian adults 124 12 µg/g 16 µg/g 5 µg/g 6 µg/g 5 µg/g 3 µg/g NA NA Frequent detection
Loewenherz et al. 1997 Reference children 33 NA 18 µg/L NA NA NA NA NA NA Higher levels in
(0–6 years, WA State) (< 15 µg/L) applicator children
Applicator children 127 NA 39 µg/L NA NA NA NA NA NA and children living
(15 µg/L) close to orchards
Children living 51 NA 28 µg/L NA NA NA NA NA NA
< 200 ft of orchard 53 µg/L
Azaroff 1999d Nonﬁeldworkers in 110 NA NA NA NA NA NA 27% 10% Adult exposures
farm families > 25 µg/L > 25 µg/L associated with
child exposures
Aprea et al. 2000b Italian children 195 15 µg/g 15 µg/g 2 µg/g 5 µg/g 3 µg/g 1 µg/g NA NA Higher levels in
children
Garcia et al. 2000a Adults and teenagers in rice-growing region
Spray period 28 250 µg/L 430 µg/L 60 µg/L NA 90 µg/L 110 µg/L NA NA No appreciable
Control period 6 250 µg/L 50 µg/L NA NA 30 µg/L 50 µg/L NA NA increase in DAPs
after spraying; no
association of DAPs
with symptoms
Hardt and Angerer 2000 German adults 54 (30 µg/L) (22 µg/L) (1 µg/L) (4 µg/L) (< 3 µg/L) (< 3 µg/L) NA NA Frequent detection
Lu et al. 2000e Reference children 14 NA 20 µg/L 3 µg/L NA NA NA 60 mg/L NA Higher levels in
(central WA) (5 µg/L) (0 µg/L) (10 mg/L) applicator children
Applicator children 49 NA 40 µg/L 5 µg/L NA NA NA NA NA
Farm children 13 NA 30 µg/L 2 µg/L NA NA NA 70 mg/L NA
(50 mg/L)
O’Rourke et al. 2000d U.S.–Mexico border 121 25% 26% 3% > µg/L 5% < 25 µg/L < 25 µg/L NA NA Levels above a
> 25 µg/L > 25 µg/L > 25 µg/L > 25 µg/L reference population
CDC 2001b General U.S. 703 1.84 µg/L 2.61 µg/L 0.51 µg/L 2.6 µg/L 0.8 µg/L 0.19 µg/L NA NA Frequent detection
(NHANES 1999) (1.67) (3.80) (0.60) (1.85) (0.70) (0.14)
Heudorf and Angerer 2001 Germans in former U.S. military housing
0–5 years of age 309 63 µg/g 77 µg/g 5 µg/g 8 µg/g 4 µg/g < 1 µg/g NA NA Higher levels in
(27) (29) (5) children
6–13 years of age 294 35 µg/g 37 µg/g 3 µg/g 5 µg/g 2 µg/g < 1 µg/g NA NA
(16) (15) (3)
14–19 years of age 59 24 µg/g 18 µg/g 0.7 µg/g 4 µg/g 1 µg/g 1 µg/g NA NA
(17) (14) (3)
≥ 20 years of age 484 28 µg/g 37 µg/g 2 µg/g 4 µg/g 1 µg/g 1 µg/g NA NA
(16) (14) (2)
Lu et al. 2001 Children (2–5 years  110 NA NA NA NA NA NA 190 50 Residential pesticide
of age; Seattle, WA) nmol/L nmol/L use associated
(110) (40) with DAPs
Mills and Zahm 2001 Adult farmworkers 18 8 µg/L 13 µg/L < 8 µg/L < 8 µg/L 8 µg/L < 8 µg/L NA NA Infrequent detection
Farm children 9 8 µg/L 14 µg/L < 8 µg/L < 8 µg/L 6 µg/L < 8 µg/L NA NA
Curl et al. 2002b Agricultural workers 213 NA NA NA NA NA NA 130 60 Children of farmers
nmol/L nmol/L have measureable
Workers’ children 211 NA NA NA NA NA NA 90 60 DAP levels; dust 
nmol/L nmol/L azinphos-methyl
levels predictive
of urinary DAP
Koch et al. 2002b Agricultural children 2–5 years of age
Spray months 44 NA NA NA NA NA NA 96 49 Increased DAP
(26/child) nmol/L nmol/L levels during
(70) (40) spraying months
Nonspray months 44 NA NA NA NA NA NA 72 35
(26/child) nmol/L nmol/L
(60) (40)
(61)
Royster et al. 2002 Toddlers in 15 26.6 µg/L NA NA 4.9 µg/L NA NA NA NA Proximity to ﬁeld
agricultural (6.63) (2.69) not associated
region of CA with DAPs
2nd visit 17 30.1 µg/L NA NA 3.8 µg/L NA NA NA NA
(8.13) (3.2)
(8.14)
Castorina et al. 2003 Pregnant women 1,365 (1.7 µg/L) (6.2 µg/L) (0.5 µg/L) (1 µg/L) (0.9 µg/L) (0 µg/L) NA NA Some calculated
(Salinas, CA) doses above U.S. EPA
benchmark dose/100
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Table 7. Continued
Study Study population No. DMP DMTP DMDTP DEP DETP DEDTP DMAP DEAP Findings
Curl et al. 2003bb Organic diet (2–6 years 18 1.1 µg/L 4.3 µg/L 0.8 µg/L 1.0 µg/L 2.7 µg/L NA 40 20 Lower DMAP levels
of age; WA State) (0.6) (2.8) (0.7) (0.7) (2.0) nmol/L nmol/L with organic diets
Regular diet (2–6 years 21 1.9 µg/L 41 µg/L 4.8 µg/L 0.8 µg/L 4.0 µg/L NA 340 30
of age; WA State) (0.6) (14) (2.1) (0.7) (3.0) nmol/L nmol/L
(170) (20)
Shalat et al. 2003c,f Children at U.S.–Mexico 41 22 µg/g 6 µg/g 0.05 µg/g 14 µg/g 12 µg/g 1 µg/g NA NA Higher levels
border (10) (0) (0) (3) (8) (0)
Occupational exposure measures
Shaﬁk et al. 1973g FL pesticide 6 20 µg/L 60 µg/L < 20 µg/L 50 µg/L 5 µg/L < 20 µg/L NA NA Differences in DAPs
formulators between exposed and
Nonexposed 6 30 µg/L 120 µg/L < 20 µg/L 1,200 µg/L 900 µg/L < 20 µg/L NA NA nonexposed
Duncan and Grifﬁth 1985h Citrus sprayers 332 170 µg/L 100 µg/L 150 µg/L 350 µg/L 250 µg/L 250 µg/L NA NA Measurable levels
Citrus harvesters 265 1,650 µg/L 500 µg/L 600 µg/L 650 µg/L 75 µg/L 60 µg/L NA NA
Grifﬁth and Duncan 1985 Citrus sprayers 332 160 µg/L 80 µg/L 110 µg/L 410 µg/L 370 µg/L 240 µg/L NA NA More frequent
Citrus harvesters 264 390 µg/L 150 µg/L 250 µg/L 90 µg/L 70 µg/L 60 µg/L NA NA detection among
sprayers; higher
levels among
harvesters
Franklin et al. 1986i Canadian applicators 23 NA 146 µg/L NA NA NA NA NA NA Metabolite
Guthion-dosed 10 NA 72 µg/L NA NA NA NA NA NA measurements more
volunteers (dermal reliable and accurate
500–6,000 µg) than dermal patch
Fenske and Lefﬁngwell 1989j Malathion applicator 1 NA 550 µg/L 630 µg/L NA NA NA NA NA Measureable levels
Drevenkar et al. 1991c Orchard sprayers 97 NA (111 µg/g) (145 µg/g) NA NA NA NA NA DAP levels are
sensitive indicators
of exposure
Aprea et al. 1994b,c,k Controls 99 NA NA NA NA NA NA 145.4 NA Applicators had
nmol/g increased DAP levels;
(143.1) using no protective
Applicator women 19 NA NA NA NA NA NA 555.6 NA equipment
with rubber gloves nmol/g increased levels
and masks (768)
Applicator women 28 NA NA NA NA NA NA 654.4 NA
with waterproof cotton nmol/g
gloves and masks (611.5)
Applicator women 28 NA NA NA NA NA NA 326.3 NA
with cotton gloves nmol/g
and masks (385.5)
Applicator women 54 NA NA NA NA NA NA 614.0 NA
with cotton gloves nmol/g
(657.5)
Men with no 13 NA NA NA NA NA NA 3568.4 NA
protective wear nmol/g
(3,227)
Takamiya 1994 Pest control 2 DMP 99,000 µg/g NA NA 97,000 µg/g NA NA NA NA Daily ﬂuctuations
operators 4 DEP in levels
Aprea et al. 1997b,c Vineyard sprayers 9 23 µg/g 32 µg/g NA NA NA NA NA NA Higher levels in
Vineyard leaf thinners 2 13 µg/g 59 µg/g NA NA NA NA NA NA vineyard sprayers
Controls 46 5 µg/g 14 µg/g NA NA NA NA NA NA and thinners
Aprea et al. 1999b Greenhouse workers
Basal 5 NA NA NA NA NA NA 183 NA No signiﬁcant
nmol/g difference in DAPs
Reentry day 2 5 NA NA NA NA NA NA 245 NA among workers
nmol/g in days following
Reentry day 4 5 NA NA NA NA NA NA 174 NA application or
nmol/g between workers
Reentry day 6 5 NA NA NA NA NA NA 354 NA and controls
nmol/g
Controls 21 NA NA NA NA NA NA 103 NA
nmol/g
Cocker et al. 2002c,l Controls 463 NA NA NA NA NA NA 195 nmol/g Nonoccupationally
(141) exposed have
Occupational 917 NA NA NA NA NA NA 292 nmol/g measurable levels;
exposures (132) differences only in
distribution tails
Lin et al. 2002m Farmers 4 NA 32 µg/L 27 µg/L NA 52 µg/L NA NA NA Measurable
preexposure differences
Farmers 4 NA 77 µg/L 164 µg/L NA 54 µg/L NA NA NA after exposure
postexposure
Continued, next pagedetected, and the median concentrations
ranged from < 1 µg/L for DETP and DEDTP
to 30 µg/L for DMP. Our median concentra-
tions were typically ≤ 1 µg/L except for DMTP,
which ranged from 1.9 to 4.2 µg/L. The
German median for DMTP was 22 µg/L.
DAPs in urine samples from 1,146
Germans living in former U.S. Air Force hous-
ing in Germany were detected with frequency
similar to that in our population, except for
DMDTP and DEDTP (Heudorf and Angerer
2001). Both the GMs and the distribution per-
centiles were signiﬁcantly higher in the German
population than in ours for each age group
evaluated. For example, the 95th percentile
DMTP concentrations for the German popula-
tion ranged from 51 to 334 µg/g creatinine for
the various age groups, whereas ours ranged
from 47 to 66 µg/g creatinine.
Other DAP data generated from reference
populations in exposure studies, mostly in
Washington State (Loewenherz et al. 1997; Lu
et al. 2000, 2001), have been reported.
Concentrations of DAPs found in reference
children from these exposure studies were gen-
erally comparable with the DAP concentrations
of children in our population-based data,
expressed either as individual DAP metabolites
or as summed DMAP and DEAP concentra-
tions; however, our data on children were
usually slightly lower.
The differences among our NHANES
DAP data and other reported reference values,
including the German and Italian data, may be
caused by a variety of factors. First, our data
were derived from samples that represent a
geographically and culturally diverse popula-
tion. An equal proportion of males and females
were sampled, and the participants represented
a wide age range. Although age, race/ethnicity,
and sex were considered covariates in our
analysis and were appropriately accounted for,
geographic diversity was not. The geographic
area in which the participants lived certainly
would have some impact on the DAP concen-
trations. Second, our data were derived from a
large enough sample population to appropri-
ately characterize background DAP concentra-
tions by minimizing the spikes in data
associated with overt pesticide exposures. The
reference data to which we have compared the
NHANES data were all derived from small,
likely more homogeneous, populations. Third,
the analytic methodology should be considered
when comparing the results. Our data were
generated using analytic methodology that is
highly selective, allowing us to minimize the
“false positive” samples, and highly sensitive,
allowing us to detect very low levels. In gen-
eral, other reference data were generated using
less selective methodology with LODs that
were higher. Given the differences in LODs
among methods where general population
DAP concentrations were evaluated, we would
have expected to detect DAPs more frequently
in the U.S. population. However, we observed
much lower detection frequencies, which can
likely be explained by the factors we mention
here. Fourth, the distribution of our data was
generated by substituting concentrations less
than the LOD with an imputed value equal to
the LOD divided by the square root of 2.
Other reference data were generated using cen-
sored data, zero, or unspecified methods for
treatment of data less than the LOD. Finally,
the differences could be due to population or
subpopulation differences in OP pesticide use
or seasonal variations.
Article | Barr et al.
198 VOLUME 112 | NUMBER 2 | February 2004 • Environmental Health Perspectives
Table 8. Frequencies of detection (%) of each DAP metabolite among general population-based studies.
Study LOD Participants Country DMP DMTP DMDTP DEP DETP DEDTP
Murphy et al. 1983 20 µg/L NHANES II USA 12 6 < 1 7 6 < 1
(1976–1980)
5,976 adults
and children
Aprea et al. 1996 ~1 µg/L 124 adults Italy 87 99 48 82 73 7
(< 10 nmol/L)
Aprea et al. 2000 2–3 µg/L 195 children Italy 96 94 34 75 48 12
Hardt and Angerer 2000 1 µg/L 54 adults Germany 96 100 89 94 46 2
(5 µg/L DMP)
Heudorf and Angerer 2001 1 µg/L 1,146 adults, Germany 79 87 32 78 45 2
(5 µg/L DMP) adolescents,
and children
CDC 2001a 0.01–0.58 µg/L 703 adults, USA 83 84 72 99 99 99
adolescents,
and children
NHANES 1999–2000 0.01–0.58 µg/L 1,949 adults, USA 53 64 53 71 53 56
adolescents,
and children
aNonweighted frequencies of detection.
Table 7. Continued
Study Study population No. DMP DMTP DMDTP DEP DETP DEDTP DMAP DEAP Findings
Poisoning or contamination measures
Bradway and Shaﬁk 1977 Nonfatal malathion 1 50,000 µg/L 96,000 µg/L 20,000 µg/L NA NA NA NA NA High levels; no death
poisoning
Richter et al. 1992 Residents of 4 NA NA NA 31, 000 µg/L NA NA NA NA Decontamination of
diazinon- home dramatically
contaminated home reduced DEP levels
After cleanup 4 NA NA NA < 10 µg/L NA NA NA NA
Davies and Peterson 1997 Parathion poisoning 1 NA NA NA 7,800 µg/L 1,500 µg/L NA NA NA High levels
Chlorpyrifos poisoning 1 NA NA NA 30,000 µg/L 30,000 µg/L NA NA NA
NA, not applicable. Concentrations shown are mean values unless otherwise indicated; median concentrations are shown in parentheses, when available. Units are either µg/L or µg/g
creatinine for individual metabolites and nmol/L or µmol/g creatinine for summed metabolites. Where noted, conversions to common units were made. 
aMean value of detectable values. bGM. cValues presented in citation converted to common units. dOnly values given in citation were percentages of values above analytic LODs. LODs
are given in the table as the value following the “<“ sign. eValues expressed as azinphos-methyl equivalents. fValues calculated from raw data. gValues estimated from ranges given in
citation. hValues estimated from charts and/or graphs. iValues calculated from total amounts excreted over 2 or 3 days assuming 1,000 mL urine excreted per day. jMaximum value
observed. kn represents number of serial urine samples. Number of control subjects was 99, and number of subjects for each exposure group was 2, 2, 2, 5, and 1, respectively. lValue
given is a composite value summing all DAP metabolites together. mMetabolite concentrations not reported for all subjects.DAP metabolites have also been measured
to assess exposure to OP pesticides in a variety
of nonoccupational exposure studies. The con-
centrations and primary findings from these
studies are outlined in Table 7. Most non-
occupational studies took place in Washington
State (Curl et al. 2002; Fenske et al. 2000;
Loewenherz et al. 1997; Lu et al. 2000, 2001),
California (Mills and Zahm 2001), and
Arizona (O’Rourke et al. 2000) and report sim-
ilar ﬁndings: Children who lived near farmland
or had a parent who was a farmer had higher
DAP concentrations than did both reference
children in the studies and our population-
based reference concentrations for children.
Many occupational exposure studies have
also been reported. Shaﬁk et al. (1973) found
concentrations of DEP and DETP as high as
2,400 and 1,600 µg/L, respectively, in workers
formulating O,O-diethyl–substituted OP pes-
ticides, such as phorate. Florida citrus sprayers
and harvesters using both O,O-dimethyl–
substituted and O,O-diethyl–substituted pesti-
cides had urinary concentrations of DAPs
ranging from 6 to 410 µg/L (Griffith and
Duncan 1985). Another study on a similar
exposure group reported DAP concentrations
as high as 3,200 µg/L (Duncan and Griffith
1985). Fenske and Leffingwell (1989)
reported DMTP and DMDTP concentrations
approaching 700 µg/L in a malathion applica-
tor in Washington State. Sprayers and leaf
thinners in Tuscany vineyards in Italy had
DMP and DMTP concentrations as high as
600 and 175 µg/L, respectively (Aprea et al.
1997). These studies all report concentrations
well in excess of the reference concentrations
we have established. However, some of the
concentrations are similar to the maximum
concentrations we observed, especially for
DMTP, indicating some similar high-end
exposures in our population.
Several incidents of nonfatal OP pesti-
cide poisonings have been reported in which
urinary DAP was measured. Davies and
Peterson (1997) reported cases in which the
concentrations of DEP and DETP were as
high as 7,800 and 1,500 µg/L, respectively,
for parathion poisoning and 30,000 and
30,000 µg/L, respectively, for chlorpyrifos
poisoning. Bradway and Shafik (1977)
reported a nonfatal malathion poisoning case
in which the DMP, DMTP, and DMDTP
urinary concentrations were 50,000, 96,000,
and 20,000 µg/L, respectively. We had a
maximum concentration for DMTP in our
population that was similar to these poison-
ing cases; health and occupation data for this
individual have not yet been evaluated.
Conclusions
We report the first U.S. population–based
reference data for DAP metabolites of OP
pesticides; these data are stratiﬁed by age, sex,
and race/ethnicity. We found that concentra-
tions of the DAPs among the various demo-
graphic subgroups had subtle, nonsigniﬁcant
differences, except for children 6–11 years of
age, who had concentrations consistently sig-
nificantly higher than did adults and some-
times signiﬁcantly higher than did adolescents.
Sex and race/ethnicity did not significantly
affect DAP concentrations. Our data indicate
that most of the U.S. population have some
exposure to OP pesticides; however, the con-
centrations we report are much lower than
those of other reference populations in the
literature.
These data will serve many purposes in
environmental public health primarily to help
minimize or prevent any adverse health out-
come that may result from exposure to these
pesticides. To help accomplish this, these data
will have many speciﬁc uses. They will be used
as reference range values by physicians and
public health officials for comparing urinary
levels of these metabolites to potentially
exposed persons or populations to assess their
relative exposure status. They will be used by
risk assessors for modeling to estimate the
intake (e.g., daily) and compare with regulated
doses, such as the U.S. EPA’s reference dose
and the Food and Drug Administration’s
acceptable daily intake. These data will be
used in many disciplines in environmental
public health to track trends in exposure over
time and to determine the effectiveness of
public health efforts, including legislation such
as the FQPA, to reduce exposures for all
Americans, but particularly for certain vulner-
able or sensitive subgroups, such as children.
These data also will help prioritize research
gaps and needs for relating human exposures
and adverse health outcomes; they will be used
for comparing human urinary levels with uri-
nary levels found in dosed animals that have
exhibited adverse health outcomes. In sum-
mary, these data serve as U.S. landmark data
that will be used in many ways, including
those mentioned above.
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